Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
MS risk factors (4%) included mononucleosis, viral CNS infection, tobacco abuse, head injury, and vitamin D deficiency, while pregnancy, measles, and viral warts were associated with a lower MS diagnosis risk.
Source: Associations Between Clinical Conditions and Multiple Sclerosis Diagnosis. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Multiple reported designs.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Given the availability of the participants' diagnoses recorded both prior and after their recruitment in the study, we conducted our analysis based on a retrospective cohort study design.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank
Multiple reported designs · Annals of Clinical and Translational Neurology · 2025
Original publication title
Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank
© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical history through ICD‐10 diagnosis codes.
Source: ObjectivesAbstract: What methods does the paper describe?
We assessed associations between 600 clinical conditions and MS risk in 477,421 individuals using Cox models adjusted for demographics, smoking, and MS polygenic risk score (MS‐PRS). Statistically significant conditions were included in a LASSO Cox regression (five‐fold cross‐validation on 70% training set) to identify key predictors, with performance assessed by the C‐index and age‐dependent area under the curve (AUC) in the 30% test set. Lastly, temporal trajectories of MS‐associated conditions were analyzed in MS cases.
Source: MethodsAbstract: Results
We identified 192 conditions associated with MS, of which only ~20% were onset symptoms. Integrating these conditions into a predictive model already including demographics and smoking, improved the C‐index from 0.65 to 0.71. Among the 30 model‐selected best predictors, ~25% were prodromal conditions, including neuromuscular diseases, thromboembolism, and depression which typically occurred more than five years before MS diagnosis. Including MS‐PRS further increased the C‐index to 0.78, with an age‐dependent AUC exceeding 0.80 in individuals over 50 years. Trajectory analysis highlighted migraine as a common early diagnosis, often followed by hypertension, depression, and dorsalgia.
Source: ResultsAbstract: Interpretation
Our findings highlight early conditions and diagnostic trajectories of MS, supporting the existence of a prodromal phase. These insights could improve MS prediction and facilitate earlier detection, particularly for late‐onset cases.
Source: InterpretationAuthors’ abstract
ABSTRACT
Objectives
Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical history through ICD‐10 diagnosis codes.
Methods
We assessed associations between 600 clinical conditions and MS risk in 477,421 individuals using Cox models adjusted for demographics, smoking, and MS polygenic risk score (MS‐PRS). Statistically significant conditions were included in a LASSO Cox regression (five‐fold cross‐validation on 70% training set) to identify key predictors, with performance assessed by the C‐index and age‐dependent area under the curve (AUC) in the 30% test set. Lastly, temporal trajectories of MS‐associated conditions were analyzed in MS cases.
Results
We identified 192 conditions associated with MS, of which only ~20% were onset symptoms. Integrating these conditions into a predictive model already including demographics and smoking, improved the C‐index from 0.65 to 0.71. Among the 30 model‐selected best predictors, ~25% were prodromal conditions, including neuromuscular diseases, thromboembolism, and depression which typically occurred more than five years before MS diagnosis. Including MS‐PRS further increased the C‐index to 0.78, with an age‐dependent AUC exceeding 0.80 in individuals over 50 years. Trajectory analysis highlighted migraine as a common early diagnosis, often followed by hypertension, depression, and dorsalgia.
Interpretation
Our findings highlight early conditions and diagnostic trajectories of MS, supporting the existence of a prodromal phase. These insights could improve MS prediction and facilitate earlier detection, particularly for late‐onset cases.
Publication and source details
Original title: Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank
Andrea Nova; Teresa Fazia; Giovanni Di Caprio; Davide Gentilini; Luisa Bernardinelli; Roberto Bergamaschi
Annals of Clinical and Translational Neurology · 2025
* Correspondence:Andrea Nova (andrea.nova01@universitadipavia.it)
© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:19:28.089210+00:00
DOI: 10.1002/acn3.70119 · PMC12516241